Clinical Trials Directory

Trials / Completed

CompletedNCT03290300

Quality of Life Impact of Nasal Airway Treatment With Aerin Medical Device

A Prospective, Multi-Center, Non-Randomized Study to Evaluate the Quality of Life Impact After Treatment of Nasal Airway Obstruction Using the Aerin Medical Vivaer Stylus

Status
Completed
Phase
Study type
Observational
Enrollment
39 (actual)
Sponsor
Aerin Medical · Industry
Sex
All
Age
22 Years
Healthy volunteers
Not accepted

Summary

Evaluation of long-term (5-year) quality of life after nasal airway obstruction treatment with the Aerin Vivaer Stylus

Detailed description

This is a prospective, non-randomized, multi-center follow-up study to collect long term quality of life (QOL) data on a cohort of patients who participated in the Aerin Medical TP258 study "A Prospective, Multi-Center, Non-Randomized Study to Evaluate Treatment of Nasal Airway Obstruction Using the Aerin Medical Device". The TP258 study followed subjects out to 26 weeks post-procedure. This QOL study will collect data at 12, 18, 24, 36, 48 and 60 months post-procedure.

Conditions

Interventions

TypeNameDescription
DEVICEVivaer StylusPrevious nasal obstruction treatment with the Aerin Medical Vivaer Stylus

Timeline

Start date
2017-10-30
Primary completion
2022-07-09
Completion
2022-07-09
First posted
2017-09-21
Last updated
2024-02-15
Results posted
2019-08-19

Locations

8 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03290300. Inclusion in this directory is not an endorsement.